title: Statins and the Kidney: Friend or Foe?
abstract: Statins essentially are cholesterol-lowering drugs that are extensively prescribed for primary and secondary prevention of cardiovascular disease. Compelling evidence suggests that the beneficial effects of statins may not only be due to controlling cholesterol levels but also due to a pleiotropic cholesterol-independent anti-inflammatory, antioxidant, endothelial-protective and plaque-stabilizing activity. Along this line, statins may also exert acute and long-term effects on renal function. We present a narrative literature review that summarizes arguments in favour or against the preventive and/or therapeutic use of statins in kidney-related diseases or complications. We also highlight the ongoing controversy regarding statin therapy in chronic and end-stage kidney disease.
authors.affiliation: ICU Department, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
authors.forename: Patrick M
authors.initials: PM
authors.lastname: Honore
authors.forename: Rita
authors.initials: R
authors.lastname: Jacobs
authors.forename: Inne
authors.initials: I
authors.lastname: Hendrickx
authors.forename: Elisabeth
authors.initials: E
authors.lastname: De Waele
authors.forename: Viola
authors.initials: V
authors.lastname: Van Gorp
authors.forename: Jouke
authors.initials: J
authors.lastname: De Regt
authors.forename: Herbert D
authors.initials: HD
authors.lastname: Spapen
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects; D007674:Kidney Diseases / Q000188:drug therapy*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors